Version 1
: Received: 9 December 2022 / Approved: 13 December 2022 / Online: 13 December 2022 (01:58:34 CET)
How to cite:
Coppola, M.; Mondola, R.; Bevione, F. Micronutrients in the Treatment of ADHD: Speculation or Opportunity?. Preprints2022, 2022120215. https://doi.org/10.20944/preprints202212.0215.v1
Coppola, M.; Mondola, R.; Bevione, F. Micronutrients in the Treatment of ADHD: Speculation or Opportunity?. Preprints 2022, 2022120215. https://doi.org/10.20944/preprints202212.0215.v1
Coppola, M.; Mondola, R.; Bevione, F. Micronutrients in the Treatment of ADHD: Speculation or Opportunity?. Preprints2022, 2022120215. https://doi.org/10.20944/preprints202212.0215.v1
APA Style
Coppola, M., Mondola, R., & Bevione, F. (2022). Micronutrients in the Treatment of ADHD: Speculation or Opportunity?. Preprints. https://doi.org/10.20944/preprints202212.0215.v1
Chicago/Turabian Style
Coppola, M., Raffaella Mondola and Francesco Bevione. 2022 "Micronutrients in the Treatment of ADHD: Speculation or Opportunity?" Preprints. https://doi.org/10.20944/preprints202212.0215.v1
Abstract
Attention Deficit Hyperactivity Disorder is a neurodevelopmental disorder characterised by core symptoms of impulsivity, locomotor hyperactivity, and inattention affecting around 5% of children and adolescents worldwide. Although this brain illness is wrongly considered a childhood disorder, increasing evidences suggest that it can persist into adulthood in about 65% of cases leading to significant clinical, socio-relational, and occupational disabilities. Pharmacological and non-pharmacological treatments currently available permit to achieve numerous benefits, in particular, if started early in childhood, however, quality of life of patients affected by ADHD could be compromised in any case in terms of self-esteem, ability to finalize projects, and personal satisfaction. In this study we evaluated the impact of micronutrient formulations on ADHD symptoms in both children and adults analyzing results of randomized, placebo-controlled trials.
Medicine and Pharmacology, Psychiatry and Mental Health
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.